Skip to Content
Merck

Interaction of drug based binuclear mixed-ligand complexes with DNA.

Bioorganic & medicinal chemistry (2009-07-08)
Mohan N Patel, Mehulsinh R Chhasatia, Deepen S Gandhi
ABSTRACT

Here in we tried to increase an antibacterial activity of ciprofloxacin drug due to formation of mixed-ligand complexes. Synthesized compounds were found to be more potent compare to drugs, ligands and metal salt against selective gram((+ve)) and gram((-ve)) organisms. Interaction of the complexes with nucleic acid (DNA) were investigated using spectroscopic technique, viscosity measurement and gel electrophoresis and it was found that the complexes bind to DNA via intercalative mode.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
o-Phenylenediamine, flaked, 99.5%
Sigma-Aldrich
1,8-Diaminonaphthalene, 99%
Sigma-Aldrich
o-Phenylenediamine, Peroxidase substrate, ≥98.0%, powder
Sigma-Aldrich
o-Phenylenediamine, tablet, 20 mg substrate per tablet
Supelco
Norfloxacin, VETRANAL®, analytical standard
Supelco
Ofloxacin, VETRANAL®, analytical standard
Supelco
Ethylenediamine, analytical standard
Sigma-Aldrich
Ethylenediamine solution, technical, 75-80%
Sigma-Aldrich
Ethylenediamine, ReagentPlus®, ≥99%
Supelco
Ciprofloxacin, VETRANAL®, analytical standard
Supelco
Enrofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
Ethylenediamine, purified by redistillation, ≥99.5%
Sigma-Aldrich
Sparfloxacin, ≥98.0% (HPLC)
Sigma-Aldrich
Levofloxacin, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Ethylenediamine, puriss. p.a., absolute, ≥99.5% (GC)
Supelco
Norfloxacin, analytical standard, ≥98% (TLC)
Sigma-Aldrich
Ethylenediamine, BioXtra
Sigma-Aldrich
Ethylenediamine, meets USP testing specifications
Sigma-Aldrich
Enrofloxacin, ≥99.0%